Clinical Trials Sponsored by Nanjing Abingen Biotech Co. Ltd

Total 1050 results

Nanjing Bioheng Biotech Co., Ltd.

Recruiting

Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases

Autoimmune Diseases | Systemic Lupus Erythematosus | Systemic Sclerosis | Sjogren's Syndrome | ANCA Associated Vasculitis | Idiopathic Inflammatory Myopathies

China
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases

Autoimmune Diseases | Systemic Sclerosis | Sjogren's Syndrome | ANCA Associated Vasculitis | Idiopathic Inflammatory Myopathies | SLE (Systemic Lupus)

China
Nanjing Immunophage Biotech Co., Ltd

Recruiting

Study of IPG1094 in Healthy Participants

Safety Issues

Australia
Nanjing RegeneCore Biotech Co., Ltd.

Recruiting

A Phase Ib Study of RC1416 Injection

Moderate to Severe Asthma

China
Nanjing RegeneCore Biotech Co., Ltd.

Completed

A Phase I Study of RC1416 Injection

Healthy Volunteers

China
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases

Systemic Sclerosis | SLE | MS | NMOSD | ANCA Associated Vasculitis (AAV) | IIM | MG

China
Nanjing RegeneCore Biotech Co., Ltd.

Recruiting

This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.

Hematologic Malignancies

China
Nanjing Immunophage Biotech Co., Ltd

Recruiting

Phase IIa Study for IPG11406 in Patients With Lupus Nephritis

Lupus Nephritis

China
Nanjing Bioheng Biotech Co., Ltd.

Not yet recruiting

A Study of RD06-04 in Patients With Active Autoimmune Diseases

Sclerosis | ANCA Associated Vasculitis | MS | NMO Spectrum Disorder | SLE (Systemic Lupus) | IIM | SS | MG

China
Nanjing Immunophage Biotech Co., Ltd

Recruiting

Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients

Solid Tumor

China
Nanjing Immunophage Biotech Co., Ltd

Recruiting

Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

Pharmacokinetics | Safety Issues | Tolerability

China, United States
Yi Miao
Nanjing Abingen Biotech Co. Ltd

Unknown

T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System

Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Bowel Cancer | Liver Cancer | Gallbladder Cancer

China
Nanjing Legend Biotech Co.

Withdrawn

A Study of LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune Diseases

Relapsed/Refractory Autoimmune Diseases

China
Changhai Hospital
Nanjing Enricnk Biotech Co., Ltd

Recruiting

The Study of Anti-CD19 CAR NK Cells in the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma

Diffuse Large B Cell Lymphoma

China
Nanjing Immunophage Biotech Co., Ltd
Zhejiang Hospital

Recruiting

Phase 1 Study for IPG11406 in Health Volunteer

Inflammatory Bowel Diseases

China
Nanjing Legend Biotech Co.

Not yet recruiting

A Study of LUCAR-G79 in Subjects With Relapsed/Refractory Autoimmune Diseases

Relapsed/Refractory Autoimmune Diseases

China
Henan Cancer Hospital
Nanjing Bioheng Biotech Co., Ltd.

Completed

RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies

Hematologic Malignancies

China
Nanjing Immunophage Biotech Co., Ltd
Novotech (Australia) Pty Limited

Not yet recruiting

A Study of Orally Administered IPG7236 in Healthy Adult Participants

Atopic Dermatitis

Australia
He Huang
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy

Acute Lymphoblastic Leukemia | Non-hodgkin Lymphoma

China
He Huang
Nanjing Bioheng Biotech Co., Ltd.

Completed

A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies

Acute Lymphoblastic Leukemia | Non-hodgkin Lymphoma

China
He Huang
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy

Non-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia

China
He Huang
Nanjing Bioheng Biotech Co., Ltd.

Completed

CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL

Neoplasms | Neoplasms by Site | Hematologic Diseases | Hematologic Neoplasms

China
He Huang
Nanjing Bioheng Biotech Co., Ltd.

Unknown

Peripheral Blood Mononuclear Cell Collection Protocol for UCART Cell Tumor Immunotherapy Study

Peripheral Blood Mononuclear Cell

China
Wuhan Union Hospital, China
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

CART Therapy | NK T-Cell Lymphoma | CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies

China
Ruijin Hospital
Nanjing Legend Biotech Co.

Recruiting

A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma

Hodgkin's Lymphoma | Anaplastic Large Cell Lymphoma

China
Peking University
Nanjing Legend Biotech Co.

Recruiting

A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC)

Advanced Gastrointestinal Tumors

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination

SARS-CoV-2 | COVID-19 Vaccine

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults

Respiratory Syncytial Virus (RSV) | RSV Infection

Australia
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years

Herpes Zoster

Australia
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Terminated

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Withdrawn

Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
Biotech Pharmaceutical Co., Ltd.
Fudan University; NanJing PLA 81 Hospital

Completed

A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer

Pancreatic Cancer

China
Sinovac Biotech Co., Ltd

Recruiting

Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)

Hand, Foot, and Mouth Disease（HFMD)

China
Biotech Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase I Clinical Trial of JH013 Injection

Healthy Subjects (HS)
Biotech Pharmaceutical Co., Ltd.

Not yet recruiting

Safety and Preliminary Clinical Activity of Itolizumab in ARDS

Acute Respiratory Distress Syndrome
Biotech Pharmaceutical Co., Ltd.

Recruiting

Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma (NOTABLE-307)

Gastric or Esophagogastric Junction Adenocarcinoma

China
SunWay Biotech Co., LTD.

Recruiting

Effect of Vigiis 101 Lactic Acid Bacteria Powder on Body Weight and Body Fat in Overweight Participants

Overweight | Body Weight | Body Fat

Taiwan
Sinovac Biotech Co., Ltd

Recruiting

A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine

Poliomyelitis | Polio

Pakistan, Bangladesh
Oneness Biotech Co., Ltd.

Recruiting

Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma

Severe Asthma

Taiwan
Meridigen Biotech Co., Ltd.

Recruiting

Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).

Osteoarthritis, Knee

Taiwan
NanoRay Biotech Co., Ltd.

Recruiting

Auger Molecular Therapy (AMT) for Malignant Cutaneous Lesions Treatment

Malignant Fungating Wound

Taiwan
Oneness Biotech Co., Ltd.

Recruiting

Evaluate Safety, Tolerability, PK, Preliminary Clinical Activity of OB318 in Patients With Advanced Solid Malignancies

Advanced Solid Malignancies

Taiwan
Sinovac Biotech Co., Ltd

Completed

Clinical Trial for Batch Consistency of EV71 Vaccine

EV71 Vaccine

China
Oneness Biotech Co., Ltd.

Terminated

Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers

Chronic Diabetic Foot Ulcers

United States
Everfront Biotech Co., Ltd.

Active, not recruiting

To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers

Amyotrophic Lateral Sclerosis

Taiwan
Eusol Biotech Co., Ltd.

Suspended

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury

Spinal Cord Injuries

Taiwan
Meridigen Biotech Co., Ltd.

Active, not recruiting

Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease Moderate

Taiwan
Glac Biotech Co., Ltd

Completed

Effects of Probiotics Improves the Endurance and Explosiveness Exercise Performance on Healthy Human.

Exercise Performance

Taiwan
Biotech Pharmaceutical Co., Ltd.

Completed

A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN (Redbull-1)

Locally Advanced Head and Neck Squamous Cell Carcinoma

China

Clinical Trials Sponsored by Nanjing Abingen Biotech Co. Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations